DRTECH Past Earnings Performance
Past criteria checks 0/6
DRTECH's earnings have been declining at an average annual rate of -14.4%, while the Medical Equipment industry saw earnings growing at 16.7% annually. Revenues have been growing at an average rate of 15.6% per year.
Key information
-14.4%
Earnings growth rate
-8.9%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 15.6% |
| Return on equity | -16.8% |
| Net Margin | -15.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
DRTECH (KOSDAQ:214680) Is Carrying A Fair Bit Of Debt
Sep 11
DRTECH Corporation's (KOSDAQ:214680) 28% Price Boost Is Out Of Tune With Revenues
Jul 17What DRTECH Corporation's (KOSDAQ:214680) 34% Share Price Gain Is Not Telling You
May 08DRTECH (KOSDAQ:214680) Is Carrying A Fair Bit Of Debt
Apr 29We Think DRTECH (KOSDAQ:214680) Has A Fair Chunk Of Debt
Apr 14Reflecting on DRTECH's (KOSDAQ:214680) Share Price Returns Over The Last Three Years
Feb 17DRTECH (KOSDAQ:214680) Is Making Moderate Use Of Debt
Dec 22
Revenue & Expenses Breakdown
How DRTECH makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 89,823 | -13,906 | 27,985 | 13,179 |
| 31 Mar 24 | 86,598 | -8,567 | 28,367 | 12,361 |
| 31 Dec 23 | 92,439 | -2,248 | 27,551 | 11,517 |
| 30 Sep 23 | 93,339 | -1,654 | 27,285 | 10,197 |
| 30 Jun 23 | 94,147 | 2,332 | 26,992 | 9,981 |
| 31 Mar 23 | 94,498 | 6,612 | 23,898 | 10,740 |
| 31 Dec 22 | 89,481 | 5,964 | 21,880 | 10,819 |
| 30 Sep 22 | 81,428 | 7,255 | 21,551 | 10,915 |
| 30 Jun 22 | 75,627 | 5,030 | 18,990 | 10,973 |
| 31 Mar 22 | 73,015 | 4,750 | 19,964 | 11,042 |
| 31 Dec 21 | 70,277 | 4,038 | 17,976 | 11,016 |
| 30 Sep 21 | 69,761 | 948 | 17,564 | 10,687 |
| 30 Jun 21 | 64,884 | -2,072 | 16,908 | 10,295 |
| 31 Mar 21 | 58,726 | -6,973 | 15,038 | 9,894 |
| 31 Dec 20 | 55,268 | -7,230 | 15,753 | 9,236 |
| 30 Sep 20 | 54,409 | -1,611 | 13,711 | 8,674 |
| 30 Jun 20 | 52,574 | 1 | 13,344 | 8,304 |
| 31 Mar 20 | 49,721 | 1,285 | 12,347 | 7,688 |
| 31 Dec 19 | 47,845 | 945 | 11,993 | 7,171 |
| 30 Sep 19 | 46,867 | 1,194 | 11,694 | 7,064 |
| 30 Jun 19 | 46,641 | 821 | 11,847 | 6,831 |
| 31 Mar 19 | 45,830 | 1,203 | 12,198 | 6,316 |
| 31 Dec 18 | 44,714 | 1,246 | 11,694 | 6,131 |
| 30 Sep 18 | 41,883 | -523 | 11,010 | 5,405 |
| 30 Jun 18 | 39,816 | -1,536 | 11,086 | 5,301 |
| 31 Mar 18 | 39,785 | -1,554 | 11,287 | 5,077 |
| 31 Dec 17 | 38,804 | -1,815 | 10,933 | 5,378 |
| 30 Sep 17 | 39,003 | -717 | 10,491 | 5,213 |
| 30 Jun 17 | 37,232 | -1,768 | 10,097 | 5,349 |
| 31 Mar 17 | 38,336 | -100 | 9,210 | 5,621 |
| 31 Dec 16 | 36,639 | -435 | 9,689 | 4,808 |
Quality Earnings: A214680 is currently unprofitable.
Growing Profit Margin: A214680 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A214680 is unprofitable, and losses have increased over the past 5 years at a rate of 14.4% per year.
Accelerating Growth: Unable to compare A214680's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A214680 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5.3%).
Return on Equity
High ROE: A214680 has a negative Return on Equity (-16.81%), as it is currently unprofitable.